Anaerobic Bacteremia: Impact of Inappropriate Therapy on Mortality
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Investigation on incidence and mortality of anaerobic bacteremia (AB) is clinically relevant in spite of its infrequent occurrence and not often explored, which report varies according to period and institutions. Therefore, it is necessary to analyze the incidence and risk factors related to mortality and assess clinical outcomes of AB in current aspect. Materials and Methods: Characteristics of AB patients and anaerobic bacteria from blood culture at a university hospital in 2012 were reviewed retrospectively. The correlation between risk factors and 28-day patient mortality was analyzed. Results: A total of 70 non-duplicated anaerobic bacteria were isolated from blood of 70 bacteremia patients in 2012. The history of cardiovascular disease as host’s risk factor was statistically significant (P = 0.0344) in univariate and multivariate analysis. Although the inappropriate therapy was not statistically significant in univariate and multivariate analysis, the survival rate of bacteremia was significantly worse in patients who had inappropriate therapy compared with those underwent appropriate therapy (hazard ratio, 5.4; 95% confidence interval, 1.7–16.9; P = 0.004). The most frequently isolated organism was Bacteroides fragilis (32 isolates, 46%), followed by Bacteroides thetaiotaomicron (10, 14 %), and non-perfringens Clostridium (7, 10%). Conclusion: The incidence of AB in 2012 was 2.3% (number of AB patients per 100 positive blood culture patients) and the mortality rate in patients with clinically significant AB was 21.4%. In addition, AB was frequently noted in patients having malignancy and the survival rate of AB was significantly worse in patients who received inappropriate therapy compared with those underwent appropriate therapy.
Abstract
Background: Investigation on incidence and mortality of anaerobic bacteremia (AB) is clinically relevant in spite of its infrequent occurrence and not often explored, which report varies according to period and institutions. Therefore, it is necessary to analyze the incidence and risk factors related to mortality and assess clinical outcomes of AB in current aspect. Materials and Methods: Characteristics of AB patients and anaerobic bacteria from blood culture at a university hospital in 2012 were reviewed retrospectively. The correlation between risk factors and 28-day patient mortality was analyzed. Results: A total of 70 non-duplicated anaerobic bacteria were isolated from blood of 70 bacteremia patients in 2012. The history of cardiovascular disease as host’s risk factor was statistically significant (P = 0.0344) in univariate and multivariate analysis. Although the inappropriate therapy was not statistically significant in univariate and multivariate analysis, the survival rate of bacteremia was significantly worse in patients who had inappropriate therapy compared with those underwent appropriate therapy (hazard ratio, 5.4; 95% confidence interval, 1.7–16.9; P = 0.004). The most frequently isolated organism was Bacteroides fragilis (32 isolates, 46%), followed by Bacteroides thetaiotaomicron (10, 14 %), and non-perfringens Clostridium (7, 10%). Conclusion: The incidence of AB in 2012 was 2.3% (number of AB patients per 100 positive blood culture patients) and the mortality rate in patients with clinically significant AB was 21.4%. In addition, AB was frequently noted in patients having malignancy and the survival rate of AB was significantly worse in patients who received inappropriate therapy compared with those underwent appropriate therapy.
참고문헌 (23)
- Washington JA 2nd, "Comparison of two commercially available media for detection of bacteremia", Appl Microbiol, 22, pp.604~607 (1971)
- Arzese A, "Anaerobe-induced bacteremia in Italy: a nationwide survey. The Italian Anaerobe Study Group", Clin Infect Dis, 20(Suppl 2), pp.S230~S232 (1995)
- Peraino VA, "Incidence and clinical significance of anaerobic bacteremia in a community hospital", Clin Infect Dis, 16(Suppl 4), pp.S288~S291 (1993)
- Vazquez F, "Anaerobic bacteremia in a general hospital: retrospective five-year analysis", Rev Infect Dis, 9, pp.1038~1043 (1987)
- Wilson JR, "Risk factors for mortality in patients with anaerobic bacteremia", Eur J Clin Microbiol Infect Dis, 23, pp.310~316 (2004)
- Salonen JH, "Clinical significance and outcome of anaerobic bacteremia", Clin Infect Dis, 26, pp.1413~1417 (1998)
- Cheng CW, "Clinical significance of and outcomes for Bacteroides fragilis bacteremia", J Microbiol Immunol Infect, 42, pp.243~250 (2009)
- Summanen P, "Wadsworth anaerobic bacteriology manual" (1993), Star Publishing Co
- Clinical and Laboratory Standards Institute, "Methods for antimicrobial susceptibility testing of anaerobic bacteria : approved standard", CLSI, ~ (2012)
- Levy MM, "2001 SCCM", ESICM, ATS, pp.SIS International sepsis definitions conference, Crit Care Med[DOI]
- Lenz R, "The distinct category of healthcare associated bloodstream infections", BMC Infect Dis, 12, pp.85~ (2012)
- Weinstein MP, "The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults", Clin Infect Dis, 24, pp.584~602 (1997)
- Brook I, "Treatment of anaerobic infection", Expert Rev Anti Infect Ther, 5, pp.991~1006 (2007)
- Nguyen MH, "Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial", Clin Infect Dis, 30, pp.870~876 (2000)
- Lassmann B, "Reemergence of anaerobic bacteremia", Clin Infect Dis, 44, pp.895~900 (2007)
- Kim HO, "Organisms isolated from blood at the Yonsei medical center, 1974-1983", Korean J Infect Dis, 17, pp.15~32 (1985)
- 고은미, "1994-2003년 한 대학병원 혈액배양에서 분리된 미생물의 분포 및세균의 항균제 감수성 양상", Annals of Laboratory Medicine, 27(4), pp.265~275 (2007), 대한진단검사의학회
- 박용정, "최근 임상검체에서의 혐기성 세균 분리 현황 및 혐기성 균혈증의 임상적 특징", Infection and Chemotherapy, 41(4), pp.216~223 (2009), 대한감염학회
- "Changing trends in Korean patients' use of health facilities"[URL]
- Yang CC, "Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital", Int J Infect Dis, 17, pp.e955~e960 (2013)
- Kornowski R, "Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer-patients", Infection, 21, pp.241~244 (1993)
- Robert R, "Prognostic factors and impact of antibiotherapy in 117cases of anaerobic bacteraemia", Eur J Clin Microbiol Infect Dis, 27, pp.671~678 (2008)
- Kollef MH, "Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients", Clin Infect Dis, 31(Suppl 4), pp.S131~S138 (2000)